Company intelligence / Profile preview

Myriad Genetics

Salt Lake City, Utah, United States

Ownership: Private
Employees: ~2700
Development stage: Other

Overview

Myriad Genetics is a pioneer in commercial genetic and molecular diagnostic testing with leading products in hereditary cancer risk, mental health pharmacogenomics, prostate tumor profiling, and women's health. The company has processed hundreds of thousands of tests annually, with expanding payer coverage and record revenue in FY2024. Its clinical results have enabled evidence-supported test adoption in oncology, mental health, and reproductive medicine, although some product lines face intense competition[1][2][4].

Therapeutic areas: PsychiatryRare DiseasesOtherOncologyWomen's Health
Modalities: Genetic testCompanion diagnosticMolecular diagnosticBiologic
Industry: Molecular Diagnostics

Partnerships

Intermountain Precision GenomicsLeading Cancer Center (2023 collaboration)

Beyond the preview

Go deeper on Myriad Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myriad Genetics.

Explore the full profile